{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2026-02-15T12:29:05.498566+00:00",
  "news": [
    {
      "title": "HighTower Advisors LLC Grows Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxORmt6cjJMTy1mR2ZWSEdxMlVueWdEbXNkQjNLUV9EaHB4MkJEdlRPaTV1MkN6eXlhckRGc3hwdjl4NGdfLWpuanRFWEI1WVczSjktT0pWNm9BVUtQZkdQX3FIR2ZRYmJxZTNxd3hLU3VfRmtTcjhvc0p4Nk1jVS01VkVRNVljQnNiN3ZDa1RYdUdVR0RFTkZKOUlSeGNEbzNnYlVBMGJUWnRHWFl6SXhUS1Z2UGR4T0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxORmt6cjJMTy1mR2ZWSEdxMlVueWdEbXNkQjNLUV9EaHB4MkJEdlRPaTV1MkN6eXlhckRGc3hwdjl4NGdfLWpuanRFWEI1WVczSjktT0pWNm9BVUtQZkdQX3FIR2ZRYmJxZTNxd3hLU3VfRmtTcjhvc0p4Nk1jVS01VkVRNVljQnNiN3ZDa1RYdUdVR0RFTkZKOUlSeGNEbzNnYlVBMGJUWnRHWFl6SXhUS1Z2UGR4T0E?oc=5\" target=\"_blank\">HighTower Advisors LLC Grows Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-15T10:23:43+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen wins European approval to challenge argenx and UCB for autoimmune market - European Biotechnology Magazine",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNaHN2NkZxc3pRbFdMMktBMXRERElZYmZqLUpNWTRsZzd1MHB5R0xZLU5ZazVWMTZBdTZBV3lRb3daZXowMTZhenROY1dqYWRLakVJOUtFLTEyRFl6YTYwN3d2alhLcE5OTTdxOG5BZlJvWFNBbUxNT085Szk2ak53QjI3XzdxejhxMUVUZXUzb0I1Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxNaHN2NkZxc3pRbFdMMktBMXRERElZYmZqLUpNWTRsZzd1MHB5R0xZLU5ZazVWMTZBdTZBV3lRb3daZXowMTZhenROY1dqYWRLakVJOUtFLTEyRFl6YTYwN3d2alhLcE5OTTdxOG5BZlJvWFNBbUxNT085Szk2ak53QjI3XzdxejhxMUVUZXUzb0I1Zw?oc=5\" target=\"_blank\">Amgen wins European approval to challenge argenx and UCB for autoimmune market</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">European Biotechnology Magazine</font>",
      "published": "2026-02-13T13:05:58+00:00",
      "source": "European Biotechnology Magazine"
    },
    {
      "title": "Amgen wins new EU approval for Uplizna in gMG - European Pharmaceutical Review",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNVdrSkFRb01GOW9CVmRQakg5dFh6aW5GWEFJWmY1NnBhUzIyVXVKejFkU0daLTBuSHBnWUpQOC1QaHdwd1dEMjE1enlxQ2djS2dseFRZVlZSVkpBVFhRS0hiTXJTUGxFbUkxa0RUWWJrVXpBRHNIVEVORW1OU05kWDJpYU1BRl9iZWN3MkdkQk5CLU9oSnRCVkt1eUwta280MlJGcEQzWWdnUERKS2xRamlDQUMwTWlEZWZj?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNVdrSkFRb01GOW9CVmRQakg5dFh6aW5GWEFJWmY1NnBhUzIyVXVKejFkU0daLTBuSHBnWUpQOC1QaHdwd1dEMjE1enlxQ2djS2dseFRZVlZSVkpBVFhRS0hiTXJTUGxFbUkxa0RUWWJrVXpBRHNIVEVORW1OU05kWDJpYU1BRl9iZWN3MkdkQk5CLU9oSnRCVkt1eUwta280MlJGcEQzWWdnUERKS2xRamlDQUMwTWlEZWZj?oc=5\" target=\"_blank\">Amgen wins new EU approval for Uplizna in gMG</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">European Pharmaceutical Review</font>",
      "published": "2026-02-13T17:36:49+00:00",
      "source": "European Pharmaceutical Review"
    },
    {
      "title": "Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN",
      "link": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQMWdvRF9KMVIyTTVEeHB4MFhIMzlNeWhfZFNrdXhiQlJoR2NHNUlMVmpaMXZSblFSUnBKM0N0dWVJazktcnExX2JLa0luNEVGdUpWQnFHRG5zVlJzX1NOX1hLTXVVaFhGdHE3TlBaN3N0d2hsNGNrV0UtRnhsZzRaNkxlX3pUZlRicFVaMldXdk95NmxlbWZGQjJWWkoxa1RndmZyR2dod19uUHJhOExpTzlLUXhZbUd4NWhFOTJ6NmZFM3p1ZXc2MTMwY05yNjFkTGRkS0xJaXhycXlQWm96MXFSTHAxQmpu?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6AFBVV95cUxQMWdvRF9KMVIyTTVEeHB4MFhIMzlNeWhfZFNrdXhiQlJoR2NHNUlMVmpaMXZSblFSUnBKM0N0dWVJazktcnExX2JLa0luNEVGdUpWQnFHRG5zVlJzX1NOX1hLTXVVaFhGdHE3TlBaN3N0d2hsNGNrV0UtRnhsZzRaNkxlX3pUZlRicFVaMldXdk95NmxlbWZGQjJWWkoxa1RndmZyR2dod19uUHJhOExpTzlLUXhZbUd4NWhFOTJ6NmZFM3p1ZXc2MTMwY05yNjFkTGRkS0xJaXhycXlQWm96MXFSTHAxQmpu?oc=5\" target=\"_blank\">Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-02-13T15:40:41+00:00",
      "source": "MSN"
    },
    {
      "title": "Amgen wins EC approval for Uplizna in gMG - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxNbDQtTjZNZXY5NU5mYVNpNWNKbkdfNFYxaGJ1XzBEOU5XallIamlhcHp5V1JlTG1NTFlBVGVmODVhckRWdjFMOE1sRTEzZEkzbWlGbFRxNU00eXVVOWRaYUZsVkU0M2ZUanZjVGtxWl9IX0g3aFFxVU82aHVtcVE1NFptQ1pWeThYM0RoeTBwdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxNbDQtTjZNZXY5NU5mYVNpNWNKbkdfNFYxaGJ1XzBEOU5XallIamlhcHp5V1JlTG1NTFlBVGVmODVhckRWdjFMOE1sRTEzZEkzbWlGbFRxNU00eXVVOWRaYUZsVkU0M2ZUanZjVGtxWl9IX0g3aFFxVU82aHVtcVE1NFptQ1pWeThYM0RoeTBwdw?oc=5\" target=\"_blank\">Amgen wins EC approval for Uplizna in gMG</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-02-12T17:08:21+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "How to watch Amgen at Citi's 2026 virtual oncology summit - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTNGd0dUM2NQNWRFWmRCRlBnU0t0cGVzY1djTmh0Q1RRUkJnRWthMk1tTnRNbHZpOTZ5amdkdGRVbHNhOVMwUTZvYk1vUlJ2NnVzNW5scXJkRUtwNGMxSUsycml4QWtEQUpLdXYzekprbGtpU2Y5ZXVEZ0dIS2pYeXNjTlhzMFNDZDA4LU1neEk5d2l1NFM0Si1uLVYtVndkOFRZSUN0LXhLcnE4UU5FcmsxUVk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitAFBVV95cUxNQTNGd0dUM2NQNWRFWmRCRlBnU0t0cGVzY1djTmh0Q1RRUkJnRWthMk1tTnRNbHZpOTZ5amdkdGRVbHNhOVMwUTZvYk1vUlJ2NnVzNW5scXJkRUtwNGMxSUsycml4QWtEQUpLdXYzekprbGtpU2Y5ZXVEZ0dIS2pYeXNjTlhzMFNDZDA4LU1neEk5d2l1NFM0Si1uLVYtVndkOFRZSUN0LXhLcnE4UU5FcmsxUVk?oc=5\" target=\"_blank\">How to watch Amgen at Citi's 2026 virtual oncology summit</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2026-02-13T21:01:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOdVpUcXM2WWpfT1FoZWFWcVViTVM3TWROY01VdWF0OVlsS0RYWWZmbzZiY2NiZHVsOXNSVHhMdE9vZzlvYk5kRmxpZlBOaHFRNWxjMWttd0JTenRoUVVRUzRzMGlOUEFVeVJJNU45QnlmdzREbHJzcFc5c2pKS1l4LUJ1d201eU8yclM4aE5WQXBnLVltbjh0WHZ0UnVqdXJGVGNXcmxuaWFlN3JBTmtWUDBrdEdnVXVtY0hBN19lQjB5MFkzZG5aYnl0cXpuQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizgFBVV95cUxOdVpUcXM2WWpfT1FoZWFWcVViTVM3TWROY01VdWF0OVlsS0RYWWZmbzZiY2NiZHVsOXNSVHhMdE9vZzlvYk5kRmxpZlBOaHFRNWxjMWttd0JTenRoUVVRUzRzMGlOUEFVeVJJNU45QnlmdzREbHJzcFc5c2pKS1l4LUJ1d201eU8yclM4aE5WQXBnLVltbjh0WHZ0UnVqdXJGVGNXcmxuaWFlN3JBTmtWUDBrdEdnVXVtY0hBN19lQjB5MFkzZG5aYnl0cXpuQQ?oc=5\" target=\"_blank\">EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2026-02-12T14:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT - Aspen Daily News",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Aspen Daily News</font>",
      "published": "2026-02-13T21:01:00+00:00",
      "source": "Aspen Daily News"
    }
  ],
  "product_launches": [
    {
      "title": "AMGEN INC SEC 10-K Report - TradingView",
      "link": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikAFBVV95cUxNTGdnTnFjZ3hJYXpiSDl4dTZMSXVyWkNENUx0dHZnQ1JBQm11VExLeE5zUktjODVqdVFGZUlpVjU0ZFpyOUNuSVNNc21naWl1TS1wbGZlQTBqYktqaG1JbmNaY3R2SXlBekVaV0s5SmdHank4a3lDVU5JRTNjRmR0R1E5M1lEQThpZkxydG9oejk?oc=5\" target=\"_blank\">AMGEN INC SEC 10-K Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2026-02-13T21:15:01+00:00",
      "source": "TradingView"
    },
    {
      "title": "Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNOGRMMXF5YlJsZk83RlJqN3ozY1VjSUlkYnpXX05zZmZCWnRoRHNrTk9IdGVYczVZVk9WTkw0MjNKYmkySWZXOUdDdGFXZWRrRjR6U0VSbmtJbkx6NkQ1bkQycGxEWDlZRVdSTzJidFBabTZLOWxkWnI0WktQMXRNX1lCS04xMmFhV3lrV1BDbGRmRlVhSnBfV1BaMmoyc3hTV3lZOTBRX08tRnRuX0hKTkplc05sN1Q2enYxSDE4X2ZkcFVVU1lENks1VUJHWFZzY2tfOUIxaFBEa1dnRkQw?oc=5\" target=\"_blank\">Amgen: Solid New-Product Uptake Offset by Legacy Erosion and Execution Risks, Warranting a Hold Rating</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-03T08:00:00+00:00",
      "source": "TipRanks"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2026-02-13",
      "close": 369.19000244140625
    },
    "history": [
      {
        "date": "2026-02-05",
        "close": 365.26898193359375
      },
      {
        "date": "2026-02-06",
        "close": 381.6753234863281
      },
      {
        "date": "2026-02-09",
        "close": 373.23382568359375
      },
      {
        "date": "2026-02-10",
        "close": 362.1406555175781
      },
      {
        "date": "2026-02-11",
        "close": 364.057373046875
      },
      {
        "date": "2026-02-12",
        "close": 363.6800231933594
      },
      {
        "date": "2026-02-13",
        "close": 369.19000244140625
      }
    ],
    "name": "Amgen Inc."
  }
}